BIO-TECHNE Corp — Director's Dealing 2014

Apr 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-04-01

Reporting Person: Kummeth Charles R. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-01	Common Stock	A	7652	—	Acquired	22652	Direct
2014-04-01	Common Stock	A	10203	—	Acquired	32855	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-01	Stock Option (Right to Buy)	$86.25	A	46316	Acquired	2021-04-01	Common Stock (46316)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$67.46	2020-04-01	Common Stock (65000)	65000	Direct
Stock Option (Right to Buy)	$67.46	2020-04-01	Common Stock (50000)	50000	Direct

Footnotes

F1: Represents an award of restricted stock for which the risk of forfeiture will lapse with respect to 2,550 shares on April 1, 2015 and 2,551 shares on April 1, 2016 and April 1, 2017.

F2: Represents an award of restricted stock for which the risk of forfeiture will lapse pursuant to performance goals.

F3: The option will vest pursuant to the following schedule: 8,125 shares on October 1, 2013, 1,354 shares on the first day of each month for the period beginning November 1, 2013 and ending March 1, 2017, and 1,361 shares on April 1, 2017.

F4: Fully exercisable pursuant to achievement of performance goals.

F5: The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018.